Endotoxin induces systemic inflammation and hepatic necroinflammation mainly through its action on toll-like receptor 4 (TLR4), and NAFLD/NASH patients have increased endotoxin levels in the blood. Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.